US 7566719
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
granted A61KA61K38/212A61K38/215
Quick answer
US patent 7566719 (Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/212, A61K38/215, A61P, A61P31/12